SMI Advisory Services’s Co-Diagnostics CODX Stock Holding History

SMI Advisory Services’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-933	Closed	-$10.8K	–	65
2025 Q3	$10.8K	Hold	933	–	–	﹤0.01%	56
2025 Q2	$7.34K	Hold	933	–	–	﹤0.01%	51
2025 Q1	$8.96K	Hold	933	–	–	﹤0.01%	43
2024 Q4	$21.3K	Hold	933	–	–	﹤0.01%	54
2024 Q3	$35.8K	Hold	933	–	–	0.01%	56
2024 Q2	$34.4K	Sell	933 -337	-27%	-$12.3K	0.01%	59
2024 Q1	$48.4K	Buy	1,270 +687	+118%	+$24.9K	0.01%	54
2023 Q4	$24.8K	Buy	+583	New	+$20.6K	0.01%	56
2023 Q1	$44.1K	Sell	583 -104	-15%	-$8.34K	0.01%	42
2022 Q4	$66.1K	Hold	687	–	–	0.02%	41
2022 Q3	$66K	Hold	687	–	–	0.02%	36
2022 Q2	$116K	Buy	687 +340	+98%	+$51.7K	0.04%	39
2022 Q1	$64K	Buy	+347	New	+$71.9K	0.02%	35

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAG

Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SMI Advisory Services's CODX Position: Q4 2025 in Review

SMI Advisory Services sold out of Co-Diagnostics (CODX) in Q4 2025, closing a stake of 933 shares — an estimated $10.8K sold.

SMI Advisory Services first reported a position in CODX in Q1 2022 and held it in 13 quarters. The position peaked at $116K in Q2 2022. 30 funds tracked by Wall St. Rank hold CODX as of Q4 2025.

SMI Advisory Services reported no remaining Co-Diagnostics position as of Q4 2025 after selling out during the quarter.
SMI Advisory Services sold 933 Co-Diagnostics shares in Q4 2025, an estimated $10.8K.
SMI Advisory Services first reported a position in Co-Diagnostics in Q1 2022 and held it in 13 quarters.
SMI Advisory Services's Co-Diagnostics position peaked at $116K in Q2 2022.
30 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2025.

Based on SMI Advisory Services's 13F filing for Q4 2025, filed 13 Jan 2026.